+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

A

Actively Recruiting

Researchers are evaluating multiple treatments for community-acquired pneumonia and other respiratory tract infections in hospitalized patients admitted to intensive care. This adaptive platform trial, called REMAP-CAP, aims to identify the effects of various interventions on patient outcomes, including survival and recovery. It also serves as a flexible research platform to study treatments during respiratory pandemics such as COVID-19, with a specific sub-platform called REMAP-COVID for evaluating COVID-19 treatments in the United States. Participants are randomized to receive one or more interventions from various treatment domains including antibiotics, corticosteroids, antivirals, immune modulators, anticoagulation strategies, and mechanical ventilation approaches. Some interventions have been closed to recruitment while others remain active, and dosing or duration often follows local clinical guidelines or specific protocols. The trial uses an adaptive design that allows modification of treatment assignments based on accumulating data and can study interactions between treatments across domains. During the study, hospitalized patients with respiratory infections will be monitored and assessed for outcomes such as 90-day survival and recovery trajectories, days alive without organ support, and quality of life at six months. Data collected include treatment responses, hospital discharge status, and mortality. The trial is designed to continue enrolling patients adaptively over time, with ongoing evaluation of multiple interventions until conclusive answers about their effects are reached.

Age: 28Days +All GendersPhase 3
408 locations
C

Actively Recruiting

Researchers are comparing two local anesthesia methods to see their effect on pain after laser treatment for pilonidal sinus disease, a common condition affecting about 2% of the population, mostly men. The study aims to find out if there is a difference in pain levels after surgery using conventional local anesthesia or tumescent local anesthesia, which may provide longer pain relief and reduce bleeding. This is a prospective, randomized study taking place from September 2025 to August 2027 at a general hospital. Participants receive either conventional local anesthesia with 2% lidocaine injected into the surgical area or tumescent local anesthesia, which is a diluted anesthetic solution including lidocaine, epinephrine, and sodium bicarbonate, injected under the skin before laser treatment using a 1470-nm radial-emitting laser fiber. Both groups undergo the same laser treatment for pilonidal sinus. Randomization is done by sealed envelopes prior to surgery. Participants will have their pain assessed using a visual analog scale VAS before surgery and on the first, second, and seventh days after surgery. Data on pain scores and demographics will be collected anonymously and assessed without bias. The main outcome measured is pain on the first day after surgery. The study ensures voluntary participation with informed consent, and no additional risks beyond standard care are expected.

Age: 18Years +All GendersPhase Not Applicable
1 location